Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | Park SM, Miyamoto DK, Han GYQ, Chan M, Curnutt NM, Tran NL, Velleca A, Kim JH, Schurer A, Chang K, Xu W, Kharas MG, Woo CM. Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells. Cancer Cell. PMID 36898380 DOI: 10.1016/j.ccell.2023.02.010 | 0.522 | |||
2022 | Tran NL, Leconte GA, Ferguson FM. Targeted Protein Degradation: Design Considerations for PROTAC Development. Current Protocols. 2: e611. PMID 36469581 DOI: 10.1002/cpz1.611 | 0.485 | |||
2021 | Sutherland MC, Mendez DL, Babbitt SE, Tillman DE, Melnikov O, Tran NL, Prizant NT, Collier AL, Kranz RG. In vitro reconstitution reveals major differences between human and bacterial cytochrome c synthases. Elife. 10. PMID 33973521 DOI: 10.7554/eLife.64891 | 0.445 | |||
2018 | Sutherland MC, Tran NL, Tillman DE, Jarodsky JM, Yuan J, Kranz RG. Structure-Function Analysis of the Bifunctional CcsBA Heme Exporter and Cytochrome Synthetase. Mbio. 9. PMID 30563894 DOI: 10.1128/Mbio.02134-18 | 0.465 | |||
Show low-probability matches. |